Cerebral Therapeutics

Cerebral Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to improving the lives of patients with severe refractory epilepsy and other uncontrolled neurological disorders. Founded by experts in neurology, neurosurgery, and drug delivery, Cerebral Therapeutics is a pioneer in intracerebroventricular (ICV) treatments for patients with neurological conditions. The company is at the forefront of developing ICV therapies for individuals with neurological disorders. Its investigational drug therapies and accompanying biomarker strategies are enabled by proprietary technology that allows for precise targeting and delivery to the central nervous system.